References
- Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric. 2014;17(5):557–563.
- Mension E, Alonso I, Castelo-Branco C. Genitourinary syndrome of menopause: current treatment options in breast cancer survivors – systematic review. Maturitas. 2021;143:47–58.
- The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992.
- Mitchell CM. How do we measure success in the treatment of genitourinary syndrome of menopause? Menopause. 2020;27(8):844–845.
- US Food and Drug Administration. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-Recommendations for clinical evaluation; [cited 2021 Jun 18]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estrogen-and-estrogenprogestin-drug-products-treat-vasomotor-symptoms-and-vulvar-and-vaginal-atrophy.
- Di Pace R, Portuesi R. Vaginal health index score and urogenital syndrome of menopause. Gazz Med Ital – Arch Sci Med. 2018;177(12):741–744.
- Roy S, Caillouette JC, Roy T, et al. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol. 2004;190(5):1272–1277.
- Meisels A. The maturation value. Acta Cytol. 1967;11(4):249.
- Mackova K, Mazzer AM, Mori Da Cunha M, et al. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. BJOG. 2021;128(6):1087–1096.
- Panayi DC, Digesu GA, Tekkis P, et al. Ultrasound measurement of vaginal wall thickness: a novel and reliable technique. Int Urogynecol J. 2010;21(10):1265–1270.